— Jubbonti® and Wyost® are first denosumab biosimilars available in Canada, reflecting the Sandoz Purpose of pioneering access for patients — Jubbonti® and...
Issued by Sandoz CanadaDistributed by GlobeNewswire Inc.12 Aug 2024Sandoz Canada head office and sales force operations certified carbon neutral by LCL Engineering, Environment & Sustainable DevelopmentCO2 emissions offset through the purchase...
Issued by Sandoz CanadaDistributed by GlobeNewswire Inc.7 Oct 2024Please login to like, dislike or bookmark this article.